Overview
Preoperative Transhepatic Arterial Chemotherapy (TAC) in the Treatment of Liver Metastasis of Resectable Colorectal Cancer
Status:
Unknown status
Unknown status
Trial end date:
2009-12-01
2009-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to investigate whether preoperative TAC is able to improve progression free survival and overall survival in patients receiving liver metastasis resection of colorectal cancer.Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Fudan UniversityTreatments:
Fluorouracil
Leucovorin
Oxaliplatin
Criteria
Inclusion Criteria:- age <= 75 years
- resectable liver metastasis
- remnant liver volume >= 70%
- without other organ metastasis or peritoneum metastasis
- without contradiction of cardiac and pulmonary diseases
Exclusion Criteria:
- age > 75 years
- unresectable liver metastasis
- remnant liver volume < 50%
- with other organ metastasis or peritoneum metastasis
- with contradiction of cardiac and pulmonary diseases